Bristol-Myers Squibb Company Operating Income

As of the most recent data (September 2026), BRM.DE shows a operating income of $13B. That compares with $7.7B in the prior-year period — up 73.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BRM.DE's operating income is now $13B (was $7.7B) — a 73.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bristol-Myers Squibb Company is outperforming or lagging.

Tracking BRM.DE's operating income over time shows whether Bristol-Myers Squibb Company is scaling, shrinking, or reshaping that part of the business. The current reading is $13B That compares with $7.7B in the prior-year period — up 73.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Bristol-Myers Squibb Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $13B) with ownership activity and broader fundamentals.

Bristol-Myers Squibb Company's operating income is $13B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.